79 results
Page 3 of 4
424B5
kveh ec3vngec9i4p85r
14 Dec 21
Prospectus supplement for primary offering
4:40pm
6-K
EX-99.4
ovkb0j2n3avi
14 Dec 21
Legend Biotech Corporation Announces Proposed Public Offering
4:27pm
6-K
EX-99.3
2yl4zlt66mnd1488u
14 Dec 21
Legend Biotech Corporation Announces Proposed Public Offering
4:27pm
6-K
zkixlexgy ygu2ji
13 Dec 21
Legend Biotech Corporation 6-K
9:00am
6-K
EX-99.1
smbh6
13 Dec 21
Legend Biotech Corporation 6-K
9:00am
6-K
EX-99.1
b2wos u41jwef
7 Dec 21
Legend Biotech Corporation Form 6-K
8:50am
6-K
EX-99.1
qgovvrnb3z
6 Dec 21
Legend Biotech Corporation 6-K
8:30am
6-K
EX-99.1
p5ufyj4wriia7f
16 Nov 21
Legend Biotech Corp. 6-K
8:30am
6-K
s7r82uj me
4 Nov 21
Legend Biotech Corp. 6-K
8:30am
6-K
EX-99.1
tpkljean2y4s
4 Nov 21
Legend Biotech Corp. 6-K
8:30am
6-K
EX-99.1
re9 kg43kli8pryd
1 Nov 21
Legend Biotech Corporation 6-K
4:00pm
6-K
EX-99.1
zhah0lz0494 vqo
13 Sep 21
Legend Biotech Corporation 6-K
9:02am
6-K
EX-99.2
e6zh5boyyk
13 Sep 21
Legend Biotech Corporation 6-K
9:02am
6-K
EX-99.1
1aaseu1cy97uh 8k
23 Aug 21
Legend Biotech Corporation 6-K
8:00am
6-K
EX-99.2
1xk q3bays21
22 Jun 21
Legend Biotech Announces Advancement of Global Manufacturing Infrastructure
8:00am
6-K
EX-99.1
7no1h1a6nlu
9 Jun 21
Legend Biotech Corporation 6-K
8:00am
6-K
zkkqv 5s99z4c
1 Jun 21
Legend Biotech Corp. 6-K
8:00am
6-K
EX-99.1
e40my svlxpen
1 Jun 21
Legend Biotech Corp. 6-K
8:00am
6-K
EX-99.1
bpoai0zdu
27 May 21
U.S. Food and Drug Administration Grants BCMA CAR-T Cilta-cel Priority Review for the Treatment for Relapsed/Refractory Multiple Myeloma
12:00am
6-K
EX-99.1
bi3t5a8amzy7rg
18 May 21
Legend Biotech Reports First Quarter 2021 Financial Results and Recent Highlights
8:09am